711 related articles for article (PubMed ID: 18929127)
1. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
[TBL] [Abstract][Full Text] [Related]
2. [The role of endocannabinoid system in physiological and pathological processes in the eye].
Nadolska K; Goś R
Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities of applying cannabinoids' in the treatment of glaucoma].
Nadolska K; Goś R
Klin Oczna; 2008; 110(7-9):314-7. PubMed ID: 19112869
[TBL] [Abstract][Full Text] [Related]
4. The Endocannabinoid System as a Therapeutic Target in Glaucoma.
Cairns EA; Baldridge WH; Kelly ME
Neural Plast; 2016; 2016():9364091. PubMed ID: 26881140
[TBL] [Abstract][Full Text] [Related]
5. The arguments for and against cannabinoids application in glaucomatous retinopathy.
Panahi Y; Manayi A; Nikan M; Vazirian M
Biomed Pharmacother; 2017 Feb; 86():620-627. PubMed ID: 28027538
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
[TBL] [Abstract][Full Text] [Related]
7. Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease.
Kokona D; Georgiou PC; Kounenidakis M; Kiagiadaki F; Thermos K
Neural Plast; 2016; 2016():8373020. PubMed ID: 26881135
[TBL] [Abstract][Full Text] [Related]
8. Basic neuroanatomy and neuropharmacology of cannabinoids.
Breivogel CS; Sim-Selley LJ
Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?
Fowler CJ; Rojo ML; Rodriguez-Gaztelumendi A
Exp Neurol; 2010 Jul; 224(1):37-47. PubMed ID: 20353772
[TBL] [Abstract][Full Text] [Related]
10. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
Rokicki W; Dorecka M; Romaniuk W
Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
[TBL] [Abstract][Full Text] [Related]
11. [Immunological aspects in glaucoma].
Istrate B
Oftalmologia; 2010; 54(2):44-7. PubMed ID: 20827910
[TBL] [Abstract][Full Text] [Related]
12. Glaucoma as a neurodegenerative disease.
Gupta N; Yücel YH
Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
[TBL] [Abstract][Full Text] [Related]
13. [Cannabinoid applications in glaucoma].
Pinar-Sueiro S; Rodríguez-Puertas R; Vecino E
Arch Soc Esp Oftalmol; 2011 Jan; 86(1):16-23. PubMed ID: 21414525
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
Chan HC; Chang RC; Koon-Ching Ip A; Chiu K; Yuen WH; Zee SY; So KF
Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
[TBL] [Abstract][Full Text] [Related]
15. Soft cannabinoid analogues as potential anti-glaucoma agents.
Buchwald A; Browne CE; Wu WM; Ji F; Bodor N
Pharmazie; 2000 Mar; 55(3):196-201. PubMed ID: 10756540
[TBL] [Abstract][Full Text] [Related]
16. Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease.
Cairns EA; Toguri JT; Porter RF; Szczesniak AM; Kelly ME
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):253-65. PubMed ID: 26565550
[TBL] [Abstract][Full Text] [Related]
17. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
18. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
Ligresti A; Petrosino S; Di Marzo V
Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
[TBL] [Abstract][Full Text] [Related]
19. Disease progression and the need for neuroprotection in glaucoma management.
Varma R; Peeples P; Walt JG; Bramley TJ
Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases.
Rapino C; Tortolani D; Scipioni L; Maccarrone M
Curr Neuropharmacol; 2018; 16(7):959-970. PubMed ID: 28738764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
